Folic acid, 5 mg tablets

    Drug formTablets

    ATC categoryVitamins, Multivitamins, Microelements

    ATC subcategoryVitamins

    Brand nameFolic acid

    Generic nameFolic acid


    Each tablet of Folic acid 5 mg contains:

    active ingredient: folic acid – 5 mg;

    excipients: microcrystalline cellulose, lactose monohydrate, ethylcellulose, sodium starch glycolate, magnesium stearate.

    Pharmacological group and ATC code
    Vitamin B component; B03BB01.

    Chemical name and CAS number
    (2S)-2-[[4-[[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoyl]amino]pentanedioic acid; 59-30-3.


    Folic acid is a member of the vitamin B group. Contains in fresh vegetables (beans, spinach, tomatoes, etc.)., also in the liver and kidneys of animals. The body is formed by intestinal microflora.

    Folic acid is reduced in the body to tetrahydrofolate, which is a coenzyme for various metabolic processes including the synthesis of purine and pyrimidine nucleotides, and hence in the synthesis of DNA; it is also involved in some amino-acid conversions, and in the formation and utilization of formate. Deficiency, which can result in megaloblastic anaemia, develops when the dietary intake is inadequate (as in malnutrition), when there is malabsorption (as in sprue), increased utilization (as in pregnancy or conditions such as haemolytic anaemia), increased loss (as in haemodialysis), or as a result of the use of folate antagonists and other drugs that interfere with normal folate metabolism.

    Folic acid deficiency during pregnancy significantly increases the risk of birth defects caused by neural tube defects (serious malformation of the fetal nervous system), also malnutrition and prematurity.



    After oral administration folic acid, connecting in the stomach with the intrinsic factor of Castle (specific glycoprotein) is sucked into the upper part of the duodenum. Folic acid contained in food is absorbed on average two times worse than the drug.
    The maximum concentration (Cmax) in blood is achieved in 30-60 minutes.


    Almost completely bounds with plasma proteins.

    Metabolism and excretion

    Folic acid is subjected to activation in the liver by the enzyme dihydrofolate reductase, undergoing rehabilitation and methylation to 5-methyltetrahydrofolate.
    Folic acid is excreted with breast milk. Hemodialysis reduces the concentration of folic acid.
    Excreted by the kidneys in an unmodified form or in the form of metabolites; partially displayed through the intestines.

    – Prevention and treatment of megaloblastic anemia caused by folic acid deficiency.
    – Prevention of neural tube defects in the fetus in the early stages of pregnancy.
    – Folic acid deficiency in chronic hemolytic states, malabsorption and also in patients undergoing dialysis.
    Dosage and administration


    For the treatment of megaloblastic anemia caused by folic acid deficiency – 5 mg once a day during 4 months. The maximum daily dose – 15 mg per day with malabsorption (violation of absorption in the gastrointestinal tract).
    In chronic hemolytic states (Mediterranean anemia [Cooley anemia], sickle cell anemia) – 5 mg once 1-7 days, depending on the diet and the degree of hemolysis.
    To prevent folate deficiency patients who are under dialysis, a similar dose administered.


    For the prevention of fetal neural tube defects and other developmental abnormalities in 4 weeks prior to and during the first 3 months of the ensuing pregnancy – 4-5 mg per day.


    For the treatment of megaloblastic anemia due to folic acid deficiency, children under the age of 1 year – 500 mcg / kg body weight 1 time a day. Older children are prescribed similar doses as for adults.
    To prevent folate deficiency children who are under dialysis: in age from 1 month to 12 years – 250 mcg / kg body weight, one time per day; older children – 5-10 mg 1 time a day.

    Adverse effects

    Folic acid is generally well tolerated. In some cases, the allergic reaction can be observed.
    From the digestive system: in some cases – nausea, vomiting.


    In pernicious anemia, folic acid should be used only in conjunction with vitamin B12. Although folic acid stimulates hematopoiesis, it does not prevent the development of neurological complications (funicular myelosis etc.).

    Long-term use of folic acid (especially at higher doses) is not recommended, since it is possible decrease in blood concentrations of vitamin B12.

    Precautions should use the preparation in patients with impaired absorption of glucose or galactose, galactosemia or lactase deficiency, since the preparation contains 87 mg of lactose in 1 tablet.

    – Increased sensitivity to folic acid.
    – Pernicious anemia (a deficiency of vitamin B12).

    Pregnancy and breastfeeding

    Folic acid can be used in pregnancy in recommended doses indicated.
    Folic acid is excreted into breast milk, therefore its use during breastfeeding is possible only on prescription.

    Drug interactions

    With simultaneous use of antiepileptic, hormonal oral contraceptives, anti-TB preparations, ethanol and folic acid antagonists (methotrexate, pyrimethamine, triamterene, trimethoprim, sulfonamides) may develop a deficiency of folic acid.

    With simultaneous use of sulfasalazine reduces the absorption of folic acid.

    With simultaneous use folic acid reduces plasma concentrations of phenytoin, phenobarbital and primidone.


    Yellow scored cylindrical tablets with a few small darker spots, the end surface of which are flat.


    Cardboard box containing 48 tablets (2 blister packets with 24 tablets).

    Expiry date

    3 years. Do not use after the expiration date.

    Prescription status

    To be dispensed with prescription.

    Storage conditions

    Store at a room temperature (15-250C), in a dry place, out of the reach of children. Protect from light.